title: Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy.
authors.affiliation: Department of Virology, Glaxo Wellcome, Inc., Research Triangle Park, North Carolina 27709, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: Vavro
authors.forename: A M
authors.initials: AM
authors.lastname: Zimmermann
authors.forename: D R
authors.initials: DR
authors.lastname: McClernon
authors.forename: S L
authors.initials: SL
authors.lastname: Kehne
authors.forename: L A
authors.initials: LA
authors.lastname: Martel
authors.forename: M E
authors.initials: ME
authors.lastname: Valentine
authors.forename: R E
authors.initials: RE
authors.lastname: McKinney
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D054303:HIV Reverse Transcriptase / Q000235:genetics; D015497:HIV-1 / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D016131:Lymphocyte Subsets / Q000276:immunology; D019888:Nelfinavir / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D016879:Salvage Therapy; D013997:Time Factors; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase; D019888:Nelfinavir